APA (7th ed.) Citation

Wu, Y., Chen, X., Wang, L., Zhou, X., Liu, Y., Ji, D., . . . Zhao, J. (2022). Histone Deacetylase Inhibitor Panobinostat Benefits the Therapeutic Efficacy of Oncolytic Herpes Simplex Virus Combined with PD-1/PD-L1 Blocking in Glioma and Squamous Cell Carcinoma Models. MDPI AG.

Chicago Style (17th ed.) Citation

Wu, Yinglin, Xiaoqing Chen, Lei Wang, Xusha Zhou, Yonghong Liu, Dongmei Ji, Peigen Ren, Grace Guoying Zhou, and Jing Zhao. Histone Deacetylase Inhibitor Panobinostat Benefits the Therapeutic Efficacy of Oncolytic Herpes Simplex Virus Combined with PD-1/PD-L1 Blocking in Glioma and Squamous Cell Carcinoma Models. MDPI AG, 2022.

MLA (9th ed.) Citation

Wu, Yinglin, et al. Histone Deacetylase Inhibitor Panobinostat Benefits the Therapeutic Efficacy of Oncolytic Herpes Simplex Virus Combined with PD-1/PD-L1 Blocking in Glioma and Squamous Cell Carcinoma Models. MDPI AG, 2022.